Pure Global
CDSCO UID IMP/IVD/2021/000424_275d568fe68aed39617f09ccef1780c2_d6ea13e4429445e9a773d7a44265fe1e

Anti-Streptolysin O (Anti-Streptolysin O )

PHYLAX PHARMACEUTICALS PVT LTD·Device Class Class B·India CDSCO·Brand: ASO
Registration details
UID
IMP/IVD/2021/000424_275d568fe68aed39617f09ccef1780c2_d6ea13e4429445e9a773d7a44265fe1e
Device class
Class B
Brand name
ASO
License holder
PHYLAX PHARMACEUTICALS PVT LTD
Approving authority
CDSCO
Product information
In vitro diagnostic particle-enhanced reagent for the quantitative determination of anti-streptolysin O (ASO) in human serum by turbidimetric immunoassay
Similar products (4)
Other products with the same name or brand
ASO Test Kit(Anti-Streptolysin O Reagent for Turbidimetry)
Brand: ASO
Fugen Biomed
Class B
RF Test Kit(Rheumatoid Factor Reagent for Turbidimetry)
Brand: ASO
Fugen Biomed
Class B
Rheumatoid Factor (Rheumatoid Factor )
Brand: ASO
PHYLAX PHARMACEUTICALS PVT LTD
Class B
ASO
Brand: ASO
Beckman Coulter India Private Limited Hisaria Warehouse Ground Floor
Class B
Other products from PHYLAX PHARMACEUTICALS PVT LTD
Products from the same license holder (2 products)
Rheumatoid Factor (Rheumatoid Factor )
Brand: ASO
Class B
C-Reactive Protein (C-Reactive Protein )
Brand: CRP
Class C
About this record

Anti-Streptolysin O (Anti-Streptolysin O ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000424_275d568fe68aed39617f09ccef1780c2_d6ea13e4429445e9a773d7a44265fe1e. This device is marketed under the brand name ASO. The license holder is PHYLAX PHARMACEUTICALS PVT LTD, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.